A microbial engineering platform that introduces beneficial traits into crops without modifying the plant genome. By engineering endophytic bacteria, the technology accelerates trait development cycles, enabling rapid response to biotic and abiotic agricultural challenges across multiple crop species.
This research program focuses on engineering plant endophytic bacteria to deliver beneficial modifications to plant biochemistry without genetically modifying the plant itself. By working through microbial partners rather than direct plant modification, the approach enables faster iteration cycles and allows new traits to be introduced promptly to established crops. This is particularly valuable for responding to emerging agricultural challenges, including biotic threats such as pests and pathogens, and abiotic stresses such as drought and salinity.
The program has two core objectives: demonstrating the value of engineered endophytes for enhancing plant care, and expanding the portfolio of engineerable microbe-plant relationships available for agricultural application.
Model endophyte system:
Endophyte library:
Validation approach:
The technology is at an early-to-mid stage of development. The model endophyte system has been validated with established tools for genetic manipulation, protein expression, and in-planta imaging. The endophyte library provides a substantial resource for expanding the range of applicable microbe-plant partnerships. Future validation will focus on demonstrating engineered trait delivery in planta, screening additional endophytes for engineering potential, and confirming colonisation across major crop species. The program requires two postdoctoral researchers working concurrently for 12 months: a synthetic biologist for microbial engineering objectives and a plant-microbe interactions specialist for colonisation assessment.
Newcastle University is a comprehensive public research university in Newcastle upon Tyne, with broad academic and translational activity. Its city‑centre Newcastle Helix innovation district—developed with Newcastle City Council and Legal & General—co‑locates researchers with companies and hosts national innovation centres to enable fast collaboration. Deep integration with Newcastle upon Tyne Hospitals NHS Foundation Trust, supported by a joint research office, enables streamlined study setup, access to clinical populations, and end‑to‑end clinical translation. Research is backed by competitive funding from UKRI councils, the National Institute for Health and Care Research, major charities, the European Union, and industry. A dedicated technology transfer office supports IP, licensing, spinouts, and knowledge‑transfer partnerships.